Trial Profile
A Randomised, Double-Blind, Placebo-Controlled Study to Determine the Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Dec 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 01 Mar 2009 Results published in Sleep.
- 24 Jan 2009 Actual initiation date changed from Nov 2006 to Dec 2006 as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.